Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
MEDIUM RISK
Score updated Oct 13, 2026

TNYA — Tenaya Therapeutics, Inc. Dilution Risk Tracker

Track TNYA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TNYA — Get alerts when the score changes →

As of October 13, 2026, Tenaya Therapeutics, Inc. (TNYA) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. Tenaya Therapeutics, Inc. has a market capitalization of $126.80M, 224.23M shares outstanding, 105 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $60.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
65
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 42%
🔄 Reverse Split model est. 65%
• 50-day avg $0.76 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise model 33%
• Under 12 months cash (10mo)
• Active ATM program with $60M remaining capacity
🔔 Track TNYA — Get forecast alerts →

Market Data

Market Cap$126.80M
Shares Outstanding224.23M
Float216.07M
Cash$87.08M
Debt$10.12M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore45/100DilutionWatch score record
Shares Outstanding224.23MVerified float table or market cache
Public Float216.07MVerified float table or market cache
Market Cap$126.80MMarket data cache
Cash Runway10.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$60.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 3.5% shares (2026Q1 vs prior)
105 institutional holders · 68.09M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 16.96M shares
#2 MILLENNIUM MANAGEMENT LLC 5.46M shares
#3 CITADEL ADVISORS LLC 4.38M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest22.92M
Days to Cover7.5
% of Float10.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-11
xbrl XBRL WARRANT 2026-03-11
4 INSIDER TRANSACTION 2026-02-26
4 INSIDER TRANSACTION 2026-02-24
4 INSIDER TRANSACTION 2026-02-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TNYA Dilution Snapshot

Tenaya Therapeutics, Inc. (TNYA) has a DilutionScore of 45/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TNYA's DilutionScore is currently 45/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 44/100 (Medium risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202645/100MEDIUM14 days
Sep 16 – Sep 29, 202644/100MEDIUM14 days
Aug 22 – Sep 15, 202645/100MEDIUM25 days
Aug 14 – Aug 21, 202650/100MEDIUM7 days
Jul 16 – Aug 13, 202645/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TNYA shares outstanding have increased 0.2% from 216.51M (Mar 2026) to 217.00M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026217.00M216.08M▲ 29.57%
Mar 14, 2026216.51M166.77M▲ 0.07%
Mar 13, 2026216.51M166.66M▲ 30.33%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TNYA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TNYA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TNYA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TNYA
TNYA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.